High Prevalence of Antiphospholipid Antibodies in Disseminated Intravascular Coagulation

• References

• 1 Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other “antiphospholipid” autoantibodies. Blood 1994; 84: 2854-2867
• 2 Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce de LeonS. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-365
• 3 Karmochkine M, Cacoub P, Dorent R, Nataf P, Piette JC, Boffa MC, Gandjbachkh I. High prevalence of antiphospholipid antibodies in pulmonary hypertension. J Rheumatol 1996; 23: 286-290
• 4 Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Antiphospholipid antibodies in sickle cell disease. Am J Hematol 1993; 42: 380-383
• 5 Tada K, Akamatsu K, Konno T, Ohuchi T, Ohkubo K, Hayama K, Yamamoto S, Wakabayashi T, Ohta Y. Clinical significance of antiphospholipid antibodies in fulminant hepatic failure. Hepato-Gastroenterol 1995; 42: 27-30
• 6 Triplett DA. Antiphospholipid antibodies and thrombosis: a consequence, coincidence, or cause?. Arch Pathol Lab Med 1993; 117: 78-88
• 7 Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yama-zaki M, Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol 1991; 38: 281-287
• 8 Kra-Oz Z, Lorber M, Shoenfeld Y, Scharff Y. Inhibitor(s) of natural anti-cardiolipin antibodies. Clin Exp Immunol 1993; 93: 265-268